dsip benefits FDA Advisers Back Looser Rules

Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8

Product Name: GHK-Cu

We also outline when to schedule follow-up assessments and what signs might indicate a need for protocol adjustment

Serious (rare): Allergic reactions, difficulty breathing, swelling